Trial Profile
EFFECTS OF ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS ON AMBULATORY BLOOD PRESSURE AND CARDIOVASCULAR FUNCTION IN HYPERTENSIVE PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2015
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary) ; Valsartan (Primary) ; Antihypertensives
- Indications Hypertension
- Focus Therapeutic Use
- 19 Sep 2015 Status changed from active, no longer recruiting to completed, as reported by University Hospital Medical Information Network - Japan record.
- 03 Nov 2008 New trial record.